Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abeona Therapeutics (ABEO) Revenue (2016 - 2025)

Abeona Therapeutics (ABEO) has 13 years of Revenue data on record, last reported at $400000.0 in Q2 2025.

  • For Q2 2025, Revenue changed N/A year-over-year to $400000.0; the TTM value through Sep 2025 reached $400000.0, changed N/A, while the annual FY2023 figure was $3.5 million, 147.52% up from the prior year.
  • Revenue reached $400000.0 in Q2 2025 per ABEO's latest filing, down from $3.5 million in the prior quarter.
  • Across five years, Revenue topped out at $3.5 million in Q2 2023 and bottomed at -$1.5 million in Q2 2021.
  • Average Revenue over 4 years is $185000.0, with a median of $68000.0 recorded in 2022.
  • Peak YoY movement for Revenue: crashed 136.67% in 2021, then skyrocketed 250.0% in 2023.
  • A 4-year view of Revenue shows it stood at -$53000.0 in 2021, then skyrocketed by 228.3% to $68000.0 in 2022, then surged by 5047.06% to $3.5 million in 2023, then crashed by 88.57% to $400000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Revenue were $400000.0 in Q2 2025, $3.5 million in Q2 2023, and $68000.0 in Q4 2022.